IRINA MORALES: Open Payments
NPI 1396494415 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 54 payments from 15 companies in 2025. Trend: 2023 $1,879 · 2024 $1,930 · 2025 $1,170
Food & beverage: $1,170
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $252 |
| PFIZER INC. | 10 | $170 |
| Novo Nordisk Inc | 6 | $136 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Amgen Inc. | 7 | $119 |
| Lilly USA, LLC | 6 | $104 |
| Exact Sciences Corporation | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Abbott Laboratories | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: GEMTESA, ELIQUIS, REXULTI, OTEZLA, MOUNJARO, Cologuard Collection Kit, Rybelsus, Ozempic.
Industry payments across FL — which companies pay providers there.
